BOULDER, Colo. - Edgewise Therapeutics, Inc. (NASDAQ:EWTX), a biopharmaceutical company specializing in muscle disease treatment with a market capitalization of $2.91 billion and an impressive 393 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback